Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis

BACKGROUND: Millions of patients receive vitamin K antagonist (VKA) therapy worldwide. Annually 0.2–1 % of all VKA users develops an intracranial hemorrhage (ICH). Prothrombin complex concentrate (PCC) is administered to restore the INR ≤ 1.5 in an attempt to limit hematoma growth. In order to facil...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurocrit Care
Autors principals: Abdoellakhan, Rahat Amadkhan, Miah, Ishita Parveen, Khorsand, Nakisa, Meijer, Karina, Jellema, Korné
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226998/
https://ncbi.nlm.nih.gov/pubmed/27052728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12028-016-0248-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars